Last reviewed · How we verify
Matching Placebo for V116 — Competitive Intelligence Brief
phase 3
Biologic
Live · refreshed every 30 min
Target snapshot
Matching Placebo for V116 (Matching Placebo for V116) — Merck Sharp & Dohme LLC. This is a placebo control formulation with no active pharmaceutical ingredient, used as a comparator in clinical trials for V116.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Matching Placebo for V116 TARGET | Matching Placebo for V116 | Merck Sharp & Dohme LLC | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Matching Placebo for V116 CI watch — RSS
- Matching Placebo for V116 CI watch — Atom
- Matching Placebo for V116 CI watch — JSON
- Matching Placebo for V116 alone — RSS
Cite this brief
Drug Landscape (2026). Matching Placebo for V116 — Competitive Intelligence Brief. https://druglandscape.com/ci/matching-placebo-for-v116. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab